HRS-2543
- Generic Name
- HRS-2543
A Study of HRS2543 in Patients With Advanced Tumors
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05068856
- Locations
- 🇨🇳
Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath